In addition, Heintza’s work illustrates that the repression or inhibition of CYP2B (e.g., CYP2B10) may exacerbate metabolic disorders and cause obesity by perturbing fatty acid metabolism, suggesting a role of CYP2B in lipid homeostasis (Heintz et al., 2019). Here, CYP2B6 is linked to metabolic disease.